Chemical biology tools for regulating RAS signaling complexity in space and time

Chemistry and Biology

Volumn 21, Issue 9, 2014, Pages 1185-1195

  Van Hattum, Hilde ^a   Waldmann, Herbert ^a,b  

^a MAX PLANCK INSTITUTE OF MOLECULAR PHYSIOLOGY   (Germany)

^b TU DORTMUND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RAS PROTEIN; MOLECULAR LIBRARY;

ARTICLE; CELL GROWTH; CELL MEMBRANE; CELL PROLIFERATION; CELL SURVIVAL; DEATH; LIPID ANALYSIS; MOLECULE; NONHUMAN; PATHOLOGY; PREVALENCE; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; SPACE; TIME; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMISTRY; HUMAN; METABOLISM; METHYLATION; MOLECULAR LIBRARY; PROTEIN PRENYLATION; SIGNAL TRANSDUCTION;

ANIMALS; CELL MEMBRANE; HUMANS; METHYLATION; PROTEIN PRENYLATION; RAS PROTEINS; SIGNAL TRANSDUCTION; SMALL MOLECULE LIBRARIES;

EID: 84910051149     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2014.08.001     Document Type: Review

References (80)

1. A. Adibekian, B.R. Martin, J.W. Chang, K.L. Hsu, K. Tsuboi, D.A. Bachovchin, A.E. Speers, S.J. Brown, T. Spicer, and V. Fernandez-Vega Confirming target engagement for reversible inhibitors in vivo by kinetically tuned activity-based probes J. Am. Chem. Soc. 134 2012 10345 10348
2. A.A. Adjei, J.N. Davis, L.M. Bruzek, C. Erlichman, and S.H. Kaufmann Synergy of the protein farnesyltransferase inhibitor SCH66336 and cisplatin in human cancer cell lines Clin. Cancer Res. 7 2001 1438 1445
3. D.J. Anderson, J.K. Durieux, K. Song, R. Alvarado, P.K. Jackson, G. Hatzivassiliou, and M.J. Ludlam Live-cell microscopy reveals small molecule inhibitor effects on MAPK pathway dynamics PLoS ONE 6 2011 e22607
4. B. Bader, K. Kuhn, D.J. Owen, H. Waldmann, A. Wittinghofer, and J. Kuhlmann Bioorganic synthesis of lipid-modified proteins for the study of signal transduction Nature 403 2000 223 226
5. C. Bentley, S.S. Jurinka, N.M. Kljavin, S. Vartanian, S.R. Ramani, L.C. Gonzalez, K. Yu, Z. Modrusan, P. Du, and R. Bourgon A requirement for wild-type Ras isoforms in mutant KRas-driven signalling and transformation Biochem. J. 452 2013 313 320
6. M.O. Bergo, G.K. Leung, P. Ambroziak, J.C. Otto, P.J. Casey, and S.G. Young Targeted inactivation of the isoprenylcysteine carboxyl methyltransferase gene causes mislocalization of K-Ras in mammalian cells J. Biol. Chem. 275 2000 17605 17610
7. N. Berndt, A.D. Hamilton, and S.M. Sebti Targeting protein prenylation for cancer therapy Nat. Rev. Cancer 11 2011 775 791
8. V.L. Boyartchuk, M.N. Ashby, and J. Rine Modulation of Ras and a-factor function by carboxyl-terminal proteolysis Science 275 1997 1796 1800
9. L. Brunsveld, J. Kuhlmann, K. Alexandrov, A. Wittinghofer, R.S. Goody, and H. Waldmann Lipidated ras and rab peptides and proteins - synthesis, structure, and function Angew. Chem. Int. Ed. Engl. 45 2006 6622 6646
10. L. Buday, P.H. Warne, and J. Downward Downregulation of the Ras activation pathway by MAP kinase phosphorylation of Sos Oncogene 11 1995 1327 1331
11. E. Bustinza-Linares, R. Kurzrock, and A.M. Tsimberidou Salirasib in the treatment of pancreatic cancer Future Oncol. 6 2010 885 891
12. P.M. Campbell, N. Boufaied, J.J. Fiordalisi, A.D. Cox, P. Falardeau, C.J. Der, and H. Gourdeau TLN-4601 suppresses growth and induces apoptosis of pancreatic carcinoma cells through inhibition of Ras-ERK MAPK signaling J. Mol. Signal. 5 2010 18
13. S. Chandarlapaty Negative feedback and adaptive resistance to the targeted therapy of cancer Cancer Discov 2 2012 311 319
14. A. Chandra, H.E. Grecco, V. Pisupati, D. Perera, L. Cassidy, F. Skoulidis, S.A. Ismail, C. Hedberg, M. Hanzal-Bayer, and A.R. Venkitaraman The GDI-like solubilizing factor PDEδ sustains the spatial organization and signalling of Ras family proteins Nat. Cell Biol. 14 2012 148 158
15. Y.X. Chen, S. Koch, K. Uhlenbrock, K. Weise, D. Das, L. Gremer, L. Brunsveld, A. Wittinghofer, R. Winter, G. Triola, and H. Waldmann Synthesis of the Rheb and K-Ras4B GTPases Angew. Chem. Int. Ed. Engl. 49 2010 6090 6095
16. S. Chong, F.B. Mersha, D.G. Comb, M.E. Scott, D. Landry, L.M. Vence, F.B. Perler, J. Benner, R.B. Kucera, and C.A. Hirvonen Single-column purification of free recombinant proteins using a self-cleavable affinity tag derived from a protein splicing element Gene 192 1997 271 281
17. COSMIC database. (2014). http://cancer.sanger.ac.uk/cancergenome/projects/cosmic/.
18. B.A. Cutts, A.K. Sjogren, K.M. Andersson, A.M. Wahlstrom, C. Karlsson, B. Swolin, and M.O. Bergo Nf1 deficiency cooperates with oncogenic K-RAS to induce acute myeloid leukemia in mice Blood 114 2009 3629 3632
19. H. Davies, G.R. Bignell, C. Cox, P. Stephens, S. Edkins, S. Clegg, J. Teague, H. Woffendin, M.J. Garnett, and W. Bottomley Mutations of the BRAF gene in human cancer Nature 417 2002 949 954
20. F.J. Dekker, O. Rocks, N. Vartak, S. Menninger, C. Hedberg, R. Balamurugan, S. Wetzel, S. Renner, M. Gerauer, and B. Schölermann Small-molecule inhibition of APT1 affects Ras localization and signaling Nat. Chem. Biol. 6 2010 449 456
21. Dong Chen, S.B. Waters, K.H. Holt, and J.E. Pessin SOS phosphorylation and disassociation of the Grb2-SOS complex by the ERK and JNK signaling pathways J. Biol. Chem. 271 1996 6328 6332
22. J. Downward Targeting RAS signalling pathways in cancer therapy Nat. Rev. Cancer 3 2003 11 22
23. G. Elad-Sfadia, R. Haklai, E. Balan, and Y. Kloog Galectin-3 augments K-Ras activation and triggers a Ras signal that attenuates ERK but not phosphoinositide 3-kinase activity J. Biol. Chem. 279 2004 34922 34930
24. S. Eser, A. Schnieke, G. Schneider, and D. Saur Oncogenic KRAS signalling in pancreatic cancer Br. J. Cancer 2014 10.1038/bjc.2014.215 Published online April 22, 2014
25. S.A. Forbes, N. Bindal, S. Bamford, C. Cole, C.Y. Kok, D. Beare, M. Jia, R. Shepherd, K. Leung, and A. Menzies COSMIC: mining complete cancer genomes in the catalogue of somatic mutations in cancer Nucleic Acids Res. 39 2011 D945 D950
26. G. Hatzivassiliou, K. Song, I. Yen, B.J. Brandhuber, D.J. Anderson, R. Alvarado, M.J. Ludlam, D. Stokoe, S.L. Gloor, and G. Vigers RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth Nature 464 2010 431 435
27. I. Heid, C. Lubeseder-Martellato, B. Sipos, P.K. Mazur, M. Lesina, R.M. Schmid, and J.T. Siveke Early requirement of Rac1 in a mouse model of pancreatic cancer Gastroenterology 141 2011 719 730 e1-e7
28. H.J. Hocker, K.J. Cho, C.Y. Chen, N. Rambahal, S.R. Sagineedu, K. Shaari, J. Stanslas, J.F. Hancock, and A.A. Gorfe Andrographolide derivatives inhibit guanine nucleotide exchange and abrogate oncogenic Ras function Proc. Natl. Acad. Sci. USA 110 2013 10201 10206
29. S.A. Holstein, and R.J. Hohl Is there a future for prenyltransferase inhibitors in cancer therapy? Curr. Opin. Pharmacol. 12 2012 704 709
30. C.A. Hrycyna, S.K. Sapperstein, S. Clarke, and S. Michaelis The Saccharomyces cerevisiae STE14 gene encodes a methyltransferase that mediates C-terminal methylation of a-factor and RAS proteins EMBO J. 10 1991 1699 1709
31. Kirax Corporation. (2014). http://kiraxcorp.com/ggti2418.html.
32. J.C. Hunter, D. Gurbania, S.B. Ficarro, M.A. Carrasco, S.M. Lim, H.G. Choi, T. Xie, J.A. Marto, Z. Chen, N.S. Gray, and K.D. Westover In situ selectivity profiling and crystal structure of SML-8-73-1, an active site inhibitor of oncogenic K-Ras G12C Proc. Natl. Acad. Sci. USA 111 2014 8895 8900
33. S.A. Ismail, Y.X. Chen, A. Rusinova, A. Chandra, M. Bierbaum, L. Gremer, G. Triola, H. Waldmann, P.I. Bastiaens, and A. Wittinghofer Arl2-GTP and Arl3-GTP regulate a GDI-like transport system for farnesylated cargo Nat. Chem. Biol. 7 2011 942 949
34. S.R. Jada, C. Matthews, M.S. Saad, A.S. Hamzah, N.H. Lajis, M.F. Stevens, and J. Stanslas Benzylidene derivatives of andrographolide inhibit growth of breast and colon cancer cells in vitro by inducing G(1) arrest and apoptosis Br. J. Pharmacol. 155 2008 641 654
35. T.A. Kale, S.A. Hsieh, M.W. Rose, and M.D. Distefano Use of synthetic isoprenoid analogues for understanding protein prenyltransferase mechanism and structure Curr. Top. Med. Chem. 3 2003 1043 1074
36. A. Kalinin, N.H. Thomä, A. Iakovenko, I. Heinemann, E. Rostkova, A.T. Constantinescu, and K. Alexandrov Expression of mammalian geranylgeranyltransferase type-II in Escherichia coli and its application for in vitro prenylation of Rab proteins Protein Expr. Purif. 22 2001 84 91
37. A. Kazi, A. Carie, M.A. Blaskovich, C. Bucher, V. Thai, S. Moulder, H. Peng, D. Carrico, E. Pusateri, and W.J. Pledger Blockade of protein geranylgeranylation inhibits Cdk2-dependent p27Kip1 phosphorylation on Thr187 and accumulates p27Kip1 in the nucleus: implications for breast cancer therapy Mol. Cell. Biol. 29 2009 2254 2263
38. K. Kuhn, D.J. Owen, B. Bader, A. Wittinghofer, J. Kuhlmann, and H. Waldmann Synthesis of functional Ras lipoproteins and fluorescent derivatives J. Am. Chem. Soc. 123 2001 1023 1035
39. S.M. Lim, K.D. Westover, S.B. Ficarro, R.A. Harrison, H.G. Choi, M.E. Pacold, M. Carrasco, J. Hunter, N.D. Kim, and T. Xie Therapeutic targeting of oncogenic K-Ras by a covalent catalytic site inhibitor Angew. Chem. Int. Ed. Engl. 53 2014 199 204
40. P. Lito, N. Rosen, and D.B. Solit Tumor adaptation and resistance to RAF inhibitors Nat. Med. 19 2013 1401 1409
41. R.B. Lobell, D. Liu, C.A. Buser, J.P. Davide, E. DePuy, K. Hamilton, K.S. Koblan, Y. Lee, S. Mosser, and S.L. Motzel Preclinical and clinical pharmacodynamic assessment of L-778,123, a dual inhibitor of farnesyl:protein transferase and geranylgeranyl:protein transferase type-I Mol. Cancer Ther. 1 2002 747 758
42. A.I. Magee, L. Gutierrez, I.A. McKay, C.J. Marshall, and A. Hall Dynamic fatty acylation of p21N-ras EMBO J. 6 1987 3353 3357
43. A.A. Marusiak, Z.C. Edwards, W. Hugo, E.W. Trotter, M.R. Girotti, N.L. Stephenson, X. Kong, M.G. Gartside, S. Fawdar, and A. Hudson Mixed lineage kinases activate MEK independently of RAF to mediate resistance to RAF inhibitors Nat. Commun. 5 2014 3901
44. W.P. Mason, K. Belanger, G. Nicholas, I. Vallières, D. Mathieu, P. Kavan, A. Desjardins, A. Omuro, and D. Reymond A phase II study of the Ras-MAPK signaling pathway inhibitor TLN-4601 in patients with glioblastoma at first progression J. Neurooncol. 107 2012 343 349
45. T. Maurer, L.S. Garrenton, A. Oh, K. Pitts, D.J. Anderson, N.J. Skelton, B.P. Fauber, B. Pan, S. Malek, and D. Stokoe Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activity Proc. Natl. Acad. Sci. USA 109 2012 5299 5304
46. P. McGeady, S. Kuroda, K. Shimizu, Y. Takai, and M.H. Gelb The farnesyl group of H-Ras facilitates the activation of a soluble upstream activator of mitogen-activated protein kinase J. Biol. Chem. 270 1995 26347 26351
47. J. Mendelsohn, and J. Baselga The EGF receptor family as targets for cancer therapy Oncogene 19 2000 6550 6565
48. Z. Mitri, T. Constantine, and R. O'Regan The HER2 receptor in breast cancer: pathophysiology, clinical use, and new advances in therapy Chemother. Res. Pract. 2012 2012 743193
49. T. Noonan, N. Brown, L. Dudycz, and G. Wright Interaction of GTP derivatives with cellular and oncogenic ras-p21 proteins J. Med. Chem. 34 1991 1302 1307
50. A. Ocana, F. Vera-Badillo, M. Al-Mubarak, A.J. Templeton, V. Corrales-Sanchez, L. Diez-Gonzalez, M.D. Cuenca-Lopez, B. Seruga, A. Pandiella, and E. Amir Activation of the PI3K/mTOR/AKT pathway and survival in solid tumors: systematic review and meta-analysis PLoS ONE 9 2014 e95219
51. C.L. Oeste, B. Díez-Dacal, F. Bray, M. García de Lacoba, B.G. de la Torre, D. Andreu, A.J. Ruiz-Sánchez, E. Pérez-Inestrosa, C.A. García-Domínguez, J.M. Rojas, and D. Pérez-Sala The C-terminus of H-Ras as a target for the covalent binding of reactive compounds modulating Ras-dependent pathways PLoS ONE 6 2011 e15866
52. J.M. Ostrem, U. Peters, M.L. Sos, J.A. Wells, and K.M. Shokat K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions Nature 503 2013 548 551
53. J.C. Otto, E. Kim, S.G. Young, and P.J. Casey Cloning and characterization of a mammalian prenyl protein-specific protease J. Biol. Chem. 274 1999 8379 8382
54. A. Patgiri, K.K. Yadav, P.S. Arora, and D. Bar-Sagi An orthosteric inhibitor of the Ras-Sos interaction Nat. Chem. Biol. 7 2011 585 587
55. A. Paz, R. Haklai, G. Elad-Sfadia, E. Ballan, and Y. Kloog Galectin-1 binds oncogenic H-Ras to mediate Ras membrane anchorage and cell transformation Oncogene 20 2001 7486 7493
56. E. Porfiri, and F. McCormick Regulation of epidermal growth factor receptor signaling by phosphorylation of the ras exchange factor hSOS1 J. Biol. Chem. 271 1996 5871 5877
57. A. Prahallad, C. Sun, S. Huang, F. Di Nicolantonio, R. Salazar, D. Zecchin, R.L. Beijersbergen, A. Bardelli, and R. Bernards Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR Nature 483 2012 100 103
58. I.A. Prior, P.D. Lewis, and C. Mattos A comprehensive survey of Ras mutations in cancer Cancer Res. 72 2012 2457 2467
59. Y. Pylayeva-Gupta, E. Grabocka, and D. Bar-Sagi RAS oncogenes: weaving a tumorigenic web Nat. Rev. Cancer 11 2011 761 774
60. O. Rocks, A. Peyker, and P.I. Bastiaens Spatio-temporal segregation of Ras signals: one ship, three anchors, many harbors Curr. Opin. Cell Biol. 18 2006 351 357
61. O. Rocks, M. Gerauer, N. Vartak, S. Koch, Z.P. Huang, M. Pechlivanis, J. Kuhlmann, L. Brunsveld, A. Chandra, and B. Ellinger The palmitoylation machinery is a spatially organizing system for peripheral membrane proteins Cell 141 2010 458 471
62. M. Rusch, T.J. Zimmermann, M. Bürger, F.J. Dekker, K. Görmer, G. Triola, A. Brockmeyer, P. Janning, T. Böttcher, and S.A. Sieber Identification of acyl protein thioesterases 1 and 2 as the cellular targets of the Ras-signaling modulators palmostatin B and M Angew. Chem. Int. Ed. Engl. 50 2011 9838 9842
63. K.S. Saini, S. Loi, E. de Azambuja, O. Metzger-Filho, M.L. Saini, M. Ignatiadis, J.E. Dancey, and M.J. Piccart-Gebhart Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer Cancer Treat. Rev. 39 2013 935 946
64. M. Schmick, N. Vartak, B. Papke, M. Kovacevic, D.C. Truxius, L. Rossmannek, and P.I. Bastiaens KRas localizes to the plasma membrane by spatial cycles of solubilization, trapping and vesicular transport Cell 157 2014 459 471
65. F. Shima, Y. Yoshikawa, M. Ye, M. Araki, S. Matsumoto, J. Liao, L. Hu, T. Sugimoto, Y. Ijiri, and A. Takeda In silico discovery of small-molecule Ras inhibitors that display antitumor activity by blocking the Ras-effector interaction Proc. Natl. Acad. Sci. USA 110 2013 8182 8187
66. L. Simpson, and R. Parsons PTEN: life as a tumor suppressor Exp. Cell Res. 264 2001 29 41
67. K.S. Smalley A pivotal role for ERK in the oncogenic behaviour of malignant melanoma? Int. J. Cancer 104 2003 527 532
68. J. Spiegel, P.M. Cromm, G. Zimmermann, T.N. Grossmann, and H. Waldmann Small molecule modulation of Ras signaling - The Holy Grail in anti-cancer drug discovery? Nat. Chem. Biol. 10 2014 613 622
69. Q. Sun, J.P. Burke, J. Phan, M.C. Burns, E.T. Olejniczak, A.G. Waterson, T. Lee, O.W. Rossanese, and S.W. Fesik Discovery of small molecules that bind to K-Ras and inhibit Sos-mediated activation Angew. Chem. Int. Ed. Engl. 51 2012 6140 6143
70. J.T. Swarthout, S. Lobo, L. Farh, M.R. Croke, W.K. Greentree, R.J. Deschenes, and M.E. Linder DHHC9 and GCP16 constitute a human protein fatty acyltransferase with specificity for H- and N-Ras J. Biol. Chem. 280 2005 31141 31148
71. N.H. Thomä, A. Iakovenko, D. Owen, A.S. Scheidig, H. Waldmann, R.S. Goody, and K. Alexandrov Phosphoisoprenoid binding specificity of geranylgeranyltransferase type II Biochemistry 39 2000 12043 12052
72. D. van der Hoeven, K.J. Cho, X. Ma, S. Chigurupati, R.G. Parton, and J.F. Hancock Fendiline inhibits K-Ras plasma membrane localization and blocks K-Ras signal transmission Mol. Cell. Biol. 33 2013 237 251
73. W. Wang, G. Fang, and J. Rudolph Ras inhibition via direct Ras binding - is there a path forward? Bioorg. Med. Chem. Lett. 22 2012 5766 5776
74. B. Weiss, G. Bollag, and K. Shannon Hyperactive Ras as a therapeutic target in neurofibromatosis type 1 Am. J. Med. Genet. 89 1999 14 22
75. A. Young, D. Lou, and F. McCormick Oncogenic and wild-type Ras play divergent roles in the regulation of mitogen-activated protein kinase signaling Cancer Discov 3 2013 112 123
76. H. Zhang, S. Li, T. Doan, F. Rieke, P.B. Detwiler, J.M. Frederick, and W. Baehr Deletion of PrBP/delta impedes transport of GRK1 and PDE6 catalytic subunits to photoreceptor outer segments Proc. Natl. Acad. Sci. USA 104 2007 8857 8862
77. S. Zimmermann, and K. Moelling Phosphorylation and regulation of Raf by Akt (protein kinase B) Science 286 1999 1741 1744
78. T.J. Zimmermann, M. Bürger, E. Tashiro, Y. Kondoh, N.E. Martinez, K. Görmer, S. Rosin-Steiner, T. Shimizu, S. Ozaki, and K. Mikoshiba Boron-based inhibitors of acyl protein thioesterases 1 and 2 ChemBioChem 14 2013 115 122
79. G. Zimmermann, B. Papke, S. Ismail, N. Vartak, A. Chandra, M. Hoffmann, S.A. Hahn, G. Triola, A. Wittinghofer, P.I. Bastiaens, and H. Waldmann Small molecule inhibition of the KRAS-PDEδ interaction impairs oncogenic KRAS signalling Nature 497 2013 638 642
80. G. Zimmermann, C. Schultz-Fademrecht, P. Küchler, S. Murarka, S. Ismail, G. Triola, P. Nussbaumer, A. Wittinghofer, and H. Waldmann Structure guided design and kinetic analysis of highly potent benzimidazole inhibitors targeting the PDEδ prenyl binding site J. Med. Chem. 57 2014 5435 5448